Adjunctive effects of apple cider vinegar on metabolic syndrome and insulin resistance in polycystic ovary syndrome patients receiving metformin: a randomized clinical trial
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-aged women, frequently associated with insulin resistance (IR) and metabolic syndrome (MetS). Given the limitations of conventional therapies, complementary interventions targeting metabolic pathways are needed. This randomized clinical trial investigated the adjunctive effects of apple cider vinegar (ACV) on MetS components and IR in PCOS patients receiving standard metformin treatment (1500 mg/day). In this 12-week randomized controlled trial, 94 women meeting the Rotterdam criteria for PCOS, NCEP ATP III criteria for MetS, and HOMA-IR > 2.5, were randomized 1:1 to receive either ACV capsules (1500 mg/day) or placebo. Primary outcomes were changes in IR and MetS components; secondary outcomes included serum testosterone, hirsutism (modified Ferriman–Gallwey score), sexual function (FSFI), and quality of life (mPCOSQ). The results showed resolution of MetS was significantly higher in the ACV group (74.5%) than controls (40.4%) (p = 0.001). Significant reductions in IR (p = 0.01), hirsutism (p = 0.003), and improvements in sexual function (p < 0.001) and quality of life (p = 0.001) were observed in the intervention group. These results demonstrate that ACV supplementation may offer a beneficial adjunctive strategy for improving metabolic and quality-of-life parameters in women with MetS, IR, and PCOS. Trial registration: IRCT20150905023897N7, registered on 11/12/2023.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 94 participants or records.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.